The Duke Clinical Research Institute (DCRI) and Protas, led by Oxford University clinical trialist Professor Sir Martin Landray, will collaborate to develop new approaches to large randomised clinical trials. Through the collaboration, the partners hope to enable better evidence-based treatments for common conditions, such as heart and kidney disease, hypertension, diabetes, stroke and Covid-19, by […]
